KPV the science.

KPV (Lys-Pro-Val) is the final three amino acids of α-MSH, a peptide hormone with well-documented roles in pigmentation and inflammation. Researchers became interested in the isolated KPV fragment because it is reported to carry much of α-MSH’s anti-inflammatory activity in a very small, simple molecule — a useful property for a research tool.

Because it is short and synthetically straightforward, KPV is widely used in laboratory models of inflammation and epithelial-barrier function.

KPV research focuses on inflammatory and barrier-related signaling:

• NF-κB signaling — studies examine KPV’s effect on this central inflammatory transcription pathway and on downstream pro-inflammatory cytokines.
• Epithelial transport & uptake — intestinal-cell models have explored uptake via peptide transporters such as PepT1.
• Barrier & wound models — effects on epithelial integrity and tissue repair in inflamed conditions.

KPV literature is preclinical, in cell-culture and animal models:

• Mucoadhesive delivery models (2021). A study examined an in-situ hydrogel capturing KPV and reported anti-inflammatory and antibacterial readouts in laboratory models.
• Wound-dressing models (2022). Research combining KPV with growth factors in a film dressing studied accelerated repair in a diabetic-wound animal model.
• Inflammation & barrier biology. Broader work has examined KPV’s effect on NF-κB signaling and epithelial-cell responses.

These are findings in cells and animals; human therapeutic use is not established.

The KPV evidence base is preclinical, concentrated in cell and animal models of inflammation and barrier function. No human safety, dosing, or efficacy is established here. KPV is supplied strictly as a research material for laboratory investigation.